$AVIR 4 SEC Filings

Filed On	Filing
23 Jun 2026	Form 4: Lucidi Bruno, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Berger Franklin M, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Berman Howard, Director Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Duncan Barbara Gayle, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Polsky Bruce, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Murphy Polly A., Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Adams Jerome M., Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Kirsch Arthur S, Director Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
20 May 2026	Form 4: Murphy Polly A., Director Bought 6,100 shares ($25.4K)
13 Mar 2026	Form 4: Corcoran Andrea, See Remarks Received 60,000 shares by exercise or conversion ($74.4K) · Acquired 60,000 Stock Option (Right to Buy) (Option Exercise/Conversion)
03 Feb 2026	Form 4: Horga Maria Arantxa, Chief Medical Officer Received 51,283 shares by exercise or conversion · Gave up 16,073 shares to cover exercise price or tax ($68.1K) · Granted 173,500 Stock Option (Right to Buy)
03 Feb 2026	Form 4: Vavricka John, Chief Commercial Officer Received 42,083 shares by exercise or conversion · Gave up 11,570 shares to cover exercise price or tax ($49.1K) · Granted 119,520 Stock Option (Right to Buy)
03 Feb 2026	Form 4: Hammond Janet Mj, Chief Development Officer Received 58,050 shares by exercise or conversion · Gave up 14,136 shares to cover exercise price or tax ($59.9K) · Granted 177,000 Stock Option (Right to Buy)
03 Feb 2026	Form 4: Corcoran Andrea, See Remarks Received 54,866 shares by exercise or conversion · Gave up 16,104 shares to cover exercise price or tax ($68.3K) · Granted 180,000 Stock Option (Right to Buy)
03 Feb 2026	Form 4: Sommadossi Jean-Pierre, Director Received 272,983 shares by exercise or conversion · Gave up 106,093 shares to cover exercise price or tax ($450K) · Received 300,000 shares by exercise or conversion ($372K)
03 Feb 2026	Form 4: Foster Wayne, EVP, Chief Accounting Officer Received 41,333 shares by exercise or conversion · Gave up 12,132 shares to cover exercise price or tax ($51.4K) · Granted 108,000 Stock Option (Right to Buy)
24 Jun 2025	Form 4: Murphy Polly A., Director Received 29,600 shares by exercise or conversion · Granted 29,600 Restricted Stock Units · Granted 41,200 Stock Option (Right to Buy)
24 Jun 2025	Form 4: Duncan Barbara Gayle, Director Received 29,600 shares by exercise or conversion · Granted 29,600 Restricted Stock Units · Granted 41,200 Stock Option (Right to Buy)
24 Jun 2025	Form 4: Berger Franklin M, Director Received 29,600 shares by exercise or conversion · Granted 29,600 Restricted Stock Units · Granted 41,200 Stock Option (Right to Buy)
24 Jun 2025	Form 4: Polsky Bruce, Director Received 29,600 shares by exercise or conversion · Granted 29,600 Restricted Stock Units · Granted 41,200 Stock Option (Right to Buy)

Comments